ADAM10 Mediates Malignant Pleural Mesothelioma Invasiveness

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2019 Jan 18

PMID 30651596

Citations 17

Authors

Christelle Sepult

Marine Bellefroid

Natacha Rocks

Kim Donati

Catherine Gerard

Christine Gilles

Andreas Ludwig

Bernard Duysinx

Agnes Noel

Didier Cataldo

Affiliations

Soon will be listed here.

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited therapeutic options and treatment efficiency. Even if the latency period between asbestos exposure, the main risk factor, and mesothelioma development is very long, the local invasion of mesothelioma is very rapid leading to a mean survival of one year after diagnosis. ADAM10 (A Disintegrin And Metalloprotease) sheddase targets membrane-bound substrates and its overexpression is associated with progression in several cancers. However, nothing is known about ADAM10 implication in MPM. In this study, we demonstrated higher ADAM10 expression levels in human MPM as compared to control pleural samples and in human MPM cell line. This ADAM10 overexpression was also observed in murine MPM samples. Two mouse mesothelioma cell lines were used in this study including one primary cell line obtained by repeated asbestos fibre injections. We show, in vitro, that ADAM10 targeting through shRNA and pharmacological (GI254023X) approaches reduced drastically mesothelioma cell migration and invasion, as well as for human mesothelioma cells treated with siRNA targeting ADAM10. Moreover, ADAM10 downregulation in murine mesothelioma cells significantly impairs MPM progression in vivo after intrapleural cell injection. We also demonstrate that ADAM10 sheddase downregulation decreases the production of a soluble N-cadherin fragment through membrane N-cadherin, which stimulated mesothelioma cell migration. Taken together, we demonstrate that ADAM10 is overexpressed in MPM and takes part to MPM progression through the generation of N-cadherin fragment that stimulates mesothelioma cell migration. ADAM10 inhibition is worth considering as a therapeutic perspective in mesothelioma context.

Citing Articles

YB-1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2.

Schelch K, Eder S, Zitta B, Phimmachanh M, Johnson T, Emminger D Mol Oncol. 2022; 18(4):815-831.

PMID: 36550787 PMC: 10994239. DOI: 10.1002/1878-0261.13367.

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

Orozco Morales M, Rinaldi C, de Jong E, Lansley S, Gummer J, Olasz B iScience. 2022; 25(1):103571.

PMID: 34984327 PMC: 8692993. DOI: 10.1016/j.isci.2021.103571.

Value of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy to treat malignant peritoneal mesothelioma.

Wang T, Li H, Ye B, Zhang D Am J Transl Res. 2021; 13(9):10712-10720.

PMID: 34650746 PMC: 8506998.

Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential.

Harrison N, Koo C, Tomlinson M Int J Mol Sci. 2021; 22(13).

PMID: 34201472 PMC: 8268256. DOI: 10.3390/ijms22136707.

Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.

Machuldova A, Holubova M, Caputo V, cedikova M, Jindra P, Houdova L Front Immunol. 2021; 12:651751.

PMID: 33868289 PMC: 8044845. DOI: 10.3389/fimmu.2021.651751.

References

Kim J, Islam S, Kim Y, Prudoff R, Sass K, Wheelock M . N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol. 2000; 151(6):1193-206. PMC: 2190584. DOI: 10.1083/jcb.151.6.1193. View

Utton M, Eickholt B, Howell F, Wallis J, Doherty P . Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells. J Neurochem. 2001; 76(5):1421-30. DOI: 10.1046/j.1471-4159.2001.00140.x. View

Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V . A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 2002; 21(8):1948-56. PMC: 125968. DOI: 10.1093/emboj/21.8.1948. View

Suyama K, Shapiro I, Guttman M, Hazan R . A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell. 2002; 2(4):301-14. DOI: 10.1016/s1535-6108(02)00150-2. View

Hundhausen C, Misztela D, Berkhout T, Broadway N, Saftig P, Reiss K . The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003; 102(4):1186-95. DOI: 10.1182/blood-2002-12-3775. View

Bot J, Whitaker D, Vivian J, Lake R, Yao V, McCauley R . Culturing mouse peritoneal mesothelial cells. Pathol Res Pract. 2003; 199(5):341-4. DOI: 10.1078/0344-0338-00427. View

Reiss K, Maretzky T, Ludwig A, Tousseyn T, De Strooper B, Hartmann D . ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J. 2005; 24(4):742-52. PMC: 549617. DOI: 10.1038/sj.emboj.7600548. View

Altomare D, You H, Xiao G, Ramos-Nino M, Skele K, De Rienzo A . Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene. 2005; 24(40):6080-9. DOI: 10.1038/sj.onc.1208744. View

Andreini C, Banci L, Bertini I, Elmi S, Rosato A . Comparative analysis of the ADAM and ADAMTS families. J Proteome Res. 2005; 4(3):881-8. DOI: 10.1021/pr0500096. View

10.

Altomare D, Vaslet C, Skele K, De Rienzo A, Devarajan K, Jhanwar S . A mouse model recapitulating molecular features of human mesothelioma. Cancer Res. 2005; 65(18):8090-5. DOI: 10.1158/0008-5472.CAN-05-2312. View

11.

Kern A, Roempp B, Prager K, Walter J, Behl C . Down-regulation of endogenous amyloid precursor protein processing due to cellular aging. J Biol Chem. 2005; 281(5):2405-13. DOI: 10.1074/jbc.M505625200. View

12.

Rocks N, Paulissen G, Quesada Calvo F, Polette M, Gueders M, Munaut C . Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer. 2006; 94(5):724-30. PMC: 2361209. DOI: 10.1038/sj.bjc.6602990. View

13.

Yaziji H, Battifora H, Barry T, Hwang H, Bacchi C, McIntosh M . Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006; 19(4):514-23. DOI: 10.1038/modpathol.3800534. View

14.

Derycke L, Morbidelli L, Ziche M, De Wever O, Bracke M, Van Aken E . Soluble N-cadherin fragment promotes angiogenesis. Clin Exp Metastasis. 2006; 23(3-4):187-201. DOI: 10.1007/s10585-006-9029-7. View

15.

Moss M, Bomar M, Liu Q, Sage H, Dempsey P, Lenhart P . The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem. 2007; 282(49):35712-21. DOI: 10.1074/jbc.M703231200. View

16.

Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M . Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie. 2007; 90(2):369-79. DOI: 10.1016/j.biochi.2007.08.008. View

17.

Moss M, Stoeck A, Yan W, Dempsey P . ADAM10 as a target for anti-cancer therapy. Curr Pharm Biotechnol. 2008; 9(1):2-8. DOI: 10.2174/138920108783497613. View

18.

Kohutek Z, Dipierro C, Redpath G, Hussaini I . ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration. J Neurosci. 2009; 29(14):4605-15. PMC: 3133728. DOI: 10.1523/JNEUROSCI.5126-08.2009. View

19.

Ray M, Kindler H . Malignant pleural mesothelioma: an update on biomarkers and treatment. Chest. 2009; 136(3):888-896. DOI: 10.1378/chest.08-2665. View

20.

Paulissen G, Rocks N, Gueders M, Crahay C, Quesada-Calvo F, Bekaert S . Role of ADAM and ADAMTS metalloproteinases in airway diseases. Respir Res. 2009; 10:127. PMC: 2805617. DOI: 10.1186/1465-9921-10-127. View